ADPT230616P00010000 Option on Adaptive Biotechnologies
| ADPT Stock | USD 2.60 0.02 0.78% |
Adaptive Biotechnologies' option chain provides insight into all available option contracts written on Adaptive Biotechnologies' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Adaptive Biotechnologies' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Adaptive option contract.
In The Money vs. Out of Money Option Contracts on Adaptive Biotechnologies
Analyzing Adaptive Biotechnologies' in-the-money options over time can help investors to take a profitable long position in Adaptive Biotechnologies regardless of its overall volatility. This is especially true when Adaptive Biotechnologies' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Adaptive Biotechnologies' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Adaptive Biotechnologies' stock while costing only a fraction of its price.
Adaptive Biotechnologies' latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 0.0 with a put-to-call open interest ratio of 0.09 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 0, with calls trading at the volume of 0. This yields a 0.0 put-to-call volume ratio. The Adaptive Biotechnologies option chain provides detailed quote and price information for the current Adaptive Biotechnologies Corp option contracts. It shows all of Adaptive Biotechnologies' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
Adaptive Biotechnologies option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Adaptive Biotechnologies' lending market. For example, when Adaptive Biotechnologies' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Adaptive Biotechnologies, he or she must hedge the risk by shorting Adaptive Biotechnologies stock over its option's life.
2024-05-17
The chart above shows Adaptive Biotechnologies' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Adaptive Biotechnologies' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Adaptive Biotechnologies' option, there is no secondary market available for investors to trade.
Adaptive Biotechnologies' stock options are financial instruments that give investors the right to buy or sell shares of Adaptive Biotechnologies common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Adaptive stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Adaptive Biotechnologies' stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptive Biotechnologies Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. Please note that buying 'in-the-money' options on Adaptive Biotechnologies lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Adaptive Biotechnologies' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Adaptive Biotechnologies contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Adaptive Stock moves the wrong way.
At this time, Adaptive Biotechnologies' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 811.6 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 10.3 K in 2024. Adaptive Current Options Market Mood
Adaptive Biotechnologies' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Adaptive Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Adaptive Biotechnologies' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Adaptive Biotechnologies' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Adaptive Biotechnologies' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Adaptive contract
Base on the Rule 16, the options market is currently suggesting that Adaptive Biotechnologies Corp will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-05-17 option contract. With Adaptive Biotechnologies trading at USD 2.6, that is roughly USD 0.0. If you think that the market is fully incorporating Adaptive Biotechnologies' daily price movement you should consider buying Adaptive Biotechnologies Corp options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Adaptive |
Purchasing Adaptive Biotechnologies options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Adaptive calls. Remember, the seller must deliver Adaptive Biotechnologies Corp stock to the call owner when a call is exercised.
Adaptive Biotechnologies Option Chain
When Adaptive Biotechnologies' strike price is surpassing the current stock price, the option contract against Adaptive Biotechnologies Corp stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Adaptive Biotechnologies' option chain is a display of a range of information that helps investors for ways to trade options on Adaptive. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Adaptive. It also shows strike prices and maturity days for a Adaptive Biotechnologies against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $2.5 | 0.6064 | 0.4565 | 36 | 2024-05-17 | 0.3 - 0.45 | 0.3 | In |
Put | 2024-05-17 PUT at $2.5 | -0.3948 | 0.6999 | 107 | 2024-05-17 | 0.1 - 0.25 | 0.25 | Out |
Put | 2024-05-17 PUT at $5.0 | -0.3716 | 0.0964 | 1 | 2024-05-17 | 2.2 - 4.7 | 2.35 | In |
Put | 2024-05-17 PUT at $7.5 | -0.5211 | 0.1099 | 0 | 2024-05-17 | 4.5 - 6.7 | 4.8 | In |
Adaptive Biotechnologies Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Adaptive Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Adaptive Biotechnologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Adaptive Biotechnologies Corporate Directors
Adaptive Biotechnologies corporate directors refer to members of an Adaptive Biotechnologies board of directors. The board of directors generally takes responsibility for the Adaptive Biotechnologies' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Adaptive Biotechnologies' board members must vote for the resolution. The Adaptive Biotechnologies board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Ronald Taylor | Independent Director | Profile | |
| Daniel Rosenberg | Director | Profile | |
| Stephen Mengert | Director | Profile | |
| Gregory Scott | Independent Director | Profile |
Already Invested in Adaptive Biotechnologies Corp?
The danger of trading Adaptive Biotechnologies Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Adaptive Biotechnologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Adaptive Biotechnologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Adaptive Biotechnologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Adaptive Biotechnologies is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Adaptive Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adaptive Biotechnologies Corp Stock. Highlighted below are key reports to facilitate an investment decision about Adaptive Biotechnologies Corp Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptive Biotechnologies Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Adaptive Stock analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Adaptive Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptive Biotechnologies. If investors know Adaptive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptive Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.56) | Revenue Per Share 1.179 | Quarterly Revenue Growth (0.17) | Return On Assets (0.17) | Return On Equity (0.58) |
The market value of Adaptive Biotechnologies is measured differently than its book value, which is the value of Adaptive that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptive Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adaptive Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptive Biotechnologies' market value can be influenced by many factors that don't directly affect Adaptive Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptive Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptive Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptive Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.